Michael Nohaile - 01 Aug 2022 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role: Director
Signature: /s/ Paul Kim as Attorney-in-fact
Issuer symbol: FLGT
Transactions as of: 01 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 10 Aug 2022, 18:08:10 UTC
Next filing: 22 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FLGT	Common Stock	Award	$0	+4,000		$0.000000	4,000	01 Aug 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FLGT	Stock Option (Right to Buy)	Award	$0	+10,000		$0.000000	10,000	01 Aug 2022	Common Stock	10,000	$59.54	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.
F2	The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.